ATE267011T1 - Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren - Google Patents

Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren

Info

Publication number
ATE267011T1
ATE267011T1 AT96944844T AT96944844T ATE267011T1 AT E267011 T1 ATE267011 T1 AT E267011T1 AT 96944844 T AT96944844 T AT 96944844T AT 96944844 T AT96944844 T AT 96944844T AT E267011 T1 ATE267011 T1 AT E267011T1
Authority
AT
Austria
Prior art keywords
inhibitors
factor
isothiazoline
isoxazoline
pyrazoline
Prior art date
Application number
AT96944844T
Other languages
English (en)
Inventor
Mimi Lifen Quan
John Wityak
Robert Anthony Galemmo Jr
Petrus F W Stouten
James Russell Pruitt
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Application granted granted Critical
Publication of ATE267011T1 publication Critical patent/ATE267011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96944844T 1995-12-21 1996-12-17 Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren ATE267011T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US950895P 1995-12-21 1995-12-21
US64690396A 1996-05-08 1996-05-08
US3066696P 1996-11-12 1996-11-12
PCT/US1996/020076 WO1997023212A1 (en) 1995-12-21 1996-12-17 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS

Publications (1)

Publication Number Publication Date
ATE267011T1 true ATE267011T1 (de) 2004-06-15

Family

ID=27358875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944844T ATE267011T1 (de) 1995-12-21 1996-12-17 Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren

Country Status (9)

Country Link
EP (1) EP0874629B1 (de)
JP (1) JP2001502655A (de)
AT (1) ATE267011T1 (de)
AU (1) AU1335897A (de)
CA (1) CA2240946C (de)
DE (1) DE69632548T2 (de)
ES (1) ES2219706T3 (de)
HR (1) HRP960597A2 (de)
WO (1) WO1997023212A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
CA2293824A1 (en) * 1997-06-19 1998-12-23 Mimi Lifen Quan (amidino)6-membered aromatics as factor xa inhibitors
US6339099B1 (en) 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
EP1007037A4 (de) 1997-06-26 2004-10-06 Lilly Co Eli Antithrombose mittel
AU9309898A (en) * 1997-09-09 1999-03-29 Du Pont Pharmaceuticals Company Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
DE19755268A1 (de) * 1997-12-12 1999-06-17 Merck Patent Gmbh Benzamidinderivate
KR20010082515A (ko) * 1998-02-17 2001-08-30 우에노 도시오 아미디노 유도체 및 그 유도체를 유효 성분으로서함유하는 약제
CA2321538A1 (en) 1998-03-27 1999-10-07 Dupont Pharmaceuticals Company Disubstituted pyrazolines and triazolines as factor xa inhibitors
DE69921994T2 (de) 1998-05-02 2005-12-01 Astrazeneca Ab Heterozyklische verbindungen mit faktor xa hemmender wirkung
GB9809349D0 (en) * 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
CA2346396C (en) * 1998-10-09 2009-04-28 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
US6319937B1 (en) * 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
CA2348740A1 (en) 1998-12-23 2000-07-06 Ruth R. Wexler Thrombin or factor xa inhibitors
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
KR20030011268A (ko) 1999-07-16 2003-02-07 브리스톨-마이어스 스퀴브 파마 컴퍼니 Ｘａ 인자 억제제로서의 질소 함유 헤테로바이사이클
GB9928568D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
CN1439008A (zh) * 2000-06-23 2003-08-27 布里斯托尔-迈尔斯斯奎布药品公司 作为因子xa抑制剂的1－(杂芳环基－苯基)－稠合吡唑衍生物
WO2002000647A1 (en) 2000-06-23 2002-01-03 Bristol-Myers Squibb Pharma Company Heteroaryl-phenyl substituted factor xa inhibitors
AU2001273040A1 (en) * 2000-06-27 2002-01-08 Du Pont Pharmaceuticals Company Factor xa inhibitors
AU2001275857A1 (en) 2000-06-29 2002-01-14 Bristol-Myers Squibb Pharma Company Thrombin or factor xa inhibitors
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
EP1443930A1 (de) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazolinderivative verwendbar als antimikrobielle agenzien
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
AU2005219788B2 (en) 2004-03-05 2010-06-03 Nissan Chemical Corporation Isoxazoline-substituted benzamide compound and noxious organism control agent
KR20140018997A (ko) 2005-01-07 2014-02-13 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
WO2007026965A1 (ja) 2005-09-02 2007-03-08 Nissan Chemical Industries, Ltd. イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
BRPI0707091B8 (pt) 2006-03-10 2018-02-14 Nissan Chemical Ind Ltd composto de isoxalina e benzaldoxima substituído ou um sal do mesmo; pesticida, agroquímico, endo- ou ecto-parasiticidapara mamíferos ou pássaros, inseticida e acaricida contendo como um ou mais ingredientes ativos selecionados a partir do composto de isoxalina substituído e o sal do mesmo
CN101583593A (zh) 2006-11-13 2009-11-18 辉瑞产品公司 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
WO2013092943A1 (en) 2011-12-23 2013-06-27 Basf Se Isothiazoline compounds for combating invertebrate pests
JP6285937B2 (ja) * 2012-09-25 2018-02-28 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 除草性および殺真菌性の５−オキシ置換３−フェニルイソオキサゾリン−５−カルボキサミドおよび５−オキシ置換３−フェニルイソオキサゾリン−５−チオアミド
US20160145222A1 (en) 2013-06-21 2016-05-26 Basf Se Methods for Controlling Pests in Soybean
CN105473584B (zh) * 2013-06-24 2020-01-31 勃林格殷格翰动物保健美国公司 噻吩-或呋喃-取代的异噻唑啉化合物
ES2821877T3 (es) 2016-07-07 2021-04-28 Bristol Myers Squibb Co Espirolactamas como inhibidores de ROCK
WO2018207950A1 (ja) * 2017-05-12 2018-11-15 横山　茂之 クラスａ ｇｐｃｒ結合性化合物改変体
RU2704967C1 (ru) * 2018-06-19 2019-11-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный педагогический университет им. К.Д. Ушинского (ЯГПУ им. К.Д. Ушинского) Карбоксамидные производные изоксазолина, способ их получения и применения для лечения воспалительных заболеваний
WO2021000297A1 (en) 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9110858D0 (en) * 1991-05-20 1991-07-10 Shell Int Research Herbicidal compounds
WO1995014682A1 (en) * 1993-11-24 1995-06-01 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
DK0730590T3 (da) * 1993-11-24 2001-03-19 Du Pont Pharm Co Isoxazolin og isozazol fibrinogenreceptorantagonister

Also Published As

Publication number Publication date
CA2240946A1 (en) 1997-07-03
CA2240946C (en) 2002-09-10
WO1997023212A1 (en) 1997-07-03
EP0874629A1 (de) 1998-11-04
AU1335897A (en) 1997-07-17
DE69632548T2 (de) 2005-06-02
DE69632548D1 (de) 2004-06-24
EP0874629B1 (de) 2004-05-19
JP2001502655A (ja) 2001-02-27
ES2219706T3 (es) 2004-12-01
EP0874629A4 (de) 1999-08-04
HRP960597A2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
ATE267011T1 (de) Isoxazolin, isothiazolin und pyrazolin als faktor xa inhibitoren
ATE165825T1 (de) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
NL300175I2 (nl) Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2.
FI942381A0 (fi) Aryylisubstituoituja heterosyklisiä yhdisteitä
DE60232510D1 (de) 5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DE602004007808D1 (de) Neue gamma secretase inhibitoren
ATE337312T1 (de) Isoxazolyl-pyrimidines als inhibitoren von src- und lck-protein-kinasen
TR200101884T2 (tr) Farnesil transferaz inhibitörleri olarak 4-merkaptopirolidin türevleri.
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
FI893751A0 (fi) Kemiska foereningar.
NZ332608A (en) alkyl 17-alpha-dichloroacetoxy-11- beta-hydroxy-androsta-1,4-diene-3-one-17-beta-carboxylates and medicaments
YU18999A (sh) Supstituisani tricikli
DE69637603D1 (de) 5-(2,3-Dialkoxyphenyl)-4,1-benzoxazepin-2-one als anti-hyperlipidämische Mittel
DE59712118D1 (de) Verwendung von nicht-peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimerischen Krankheit
MA27257A1 (fr) Composes utiles pour le traitement du charbon et l'inhibition du gene letal
DE60215368D1 (de) Pyranderivate als inhibitoren von ace und nep
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
KR950010873A (ko) 화장품
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DK659089A (da) Mevalonolactoner af pyrazolopyridintypen
TR200102205T2 (tr) Anti-konvülsan türevlerinin bulimia nevruza tedavisinde kullanılmaları.
WO2000008005A3 (de) Piperazinonderivate
EP1023062A4 (de) Antibakterielle carbapeneme, zusammensetzungen und verfahren zur behandlung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties